Drug application
REPRONEX (MENOTROPINS (FSH, LH))
Drugs@FDA BLA 021047 · FERRING
Key facts
| Drug name | REPRONEX |
|---|---|
| Active ingredients | MENOTROPINS (FSH, LH) |
| Application type | BLA |
| Application number | 021047 |
| Company | FERRING |
| Dosage forms | INJECTABLE, INTRAMUSCULAR, SUBCUTANEOUS |
| Strength | 75 IU/VIAL;75 IU/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Aug 27, 1999 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: